PARNAX LAB
|
The Current P/E Ratio of PARNAX LAB is 10.79.
Share Price | ₹108.3 | Jul 18,2025 |
Market Cap | ₹124.5 Cr | |
Earnings-TTM | ₹11.5 Cr | TTM-Consolidated Results |
Price/Earnings | 10.79x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of PARNAX LAB
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹124.5 Cr] as on Jul 18,2025
(/) Earnings [ ₹11.5 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 10.79x ]
Thus, for PARNAX LAB , the investors are currently willing to pay 10.79 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of PARNAX LAB !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of PARNAX LAB over the last five years.
Historical PE (Price/Earnings) ratio chart of PARNAX LAB
PE Ratio Performance Analysis for PARNAX LAB
- PARNAX LAB 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 7.62x.
- PARNAX LAB 's operated at median p/e ratio of 6.94x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, PARNAX LAB 's p/e ratio peaked in Mar2022 at 15.68x.
- PARNAX LAB 's p/e ratio hit its five-year low in Mar2021 of 0x.
How does PARNAX LAB 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
PARNAX LAB | 11.54 | 10.79 | 124.5 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 10,980.10 | 37.00 | 406,267.0 |
DIVIS LABORATORIES LTD | 2,191.00 | 81.55 | 178,672.0 |
CIPLA LTD | 5,291.05 | 22.63 | 119,713.0 |
TORRENT PHARMACEUTICALS LTD | 1,911.00 | 62.37 | 119,195.0 |
DR REDDYS LABORATORIES LTD | 5,703.50 | 18.41 | 104,999.0 |
MANKIND PHARMA LTD | 2,003.22 | 54.66 | 109,495.0 |
ZYDUS LIFESCIENCES LTD | 4,614.80 | 21.26 | 98,133.0 |
LUPIN LTD | 3,306.26 | 26.67 | 88,191.1 |
AUROBINDO PHARMA LTD | 3,515.26 | 18.82 | 66,167.8 |
ABBOTT INDIA LTD | 1,414.44 | 51.30 | 72,563.9 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs PARNAX LAB 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 10.79x |
Max industry PE | 81.55x |
Median industry PE | 26.67x |
Average industry PE | 36.86x |
You may also like the below Video Courses